If you’ve been watching IBM (IBM) stock recently, odds are you’ve been pretty underwhelmed. Shares of the old-school tech giant hit fresh five-year lows earlier this month, and in the third quarter, revenues fell for a14th consecutive quarter.
It sounds like a business in decline, and it is. But IBM’s savvy investments in the cloud, analytics, healthcare — and the convergence of the three — are poised to pay off big time.
Big Blue, while it has the image of an antiquated, slow-moving blue chip with little breakout potential, has been quietly doubling down on Watson Health (a division of Watson, its cognitive computing initiative). For the full article click here
from health IT caucus http://ift.tt/1MzxMnG
via IFTTT
No comments:
Post a Comment